Patents, and technology Transfer WIPO Model Law for Developing Countries on Inventions United International Bureaux for the Protection of Intellectual of Intellectual Property (B.I.R.P.I). 1965. (link) WIPO Model Law For Developing Countries on Inventions, Vol 1. Patents WIPO Publication No.… Continue Reading
What is the role of model laws in norm setting for intellectual property? DATE: Tuesday, 14 March 2023 TIME: 18:00 to 20:00 VENUE: Room B CONVENER: Knowledge Ecology International (KEI) Knowledge Ecology International (KEI) cordially invites you to attend our… Continue Reading
Brazil-CL-Pandemics-KEI-10April2020 April 10, 2020 Members of the Brazil Congress It is our understanding that some large drug companies have raised objections to a new compulsory licensing authority for Brazil relating to pandemics. I would like to address the several objections… Continue Reading
A House coronavirus stimulus bill contains a provision concerning the use of Other Transactions Authority to fund COVID-19 diagnostics. The provision appears to authorize the Department of Homeland Security (DHS) to award $2.2 billion to private sector companies to develop… Continue Reading
For more on KEI’s work on COVID-19, see keionline.org/coronavirus. On March 23, 2020, Knowledge Ecology International (KEI) sent a letter to Speaker Nancy Pelosi regarding a provision in the current draft of the Senate version of the coronavirus funding bill… Continue Reading
This is a copy of the “We PAID Act” by Senators Chris van Hollen (D-MD) and Rick Scott (R-FL). The We PAID Act The 31 page bill creates a new non-profit organization to determine reasonable prices for drugs that use… Continue Reading
On April 30, 2019, KEI issued a memorandum to Congress concerning recent proposed measures to cap drug price increases and to increase the transparency of pharmaceutical research and development costs. Congress is currently considering several bills that touch on these… Continue Reading
The following are comments by the KEI on the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, in response to notice in the Federal Register, 83 FR 22692. Overall, the Blueprint is very weak, and won’t do much… Continue Reading
In a 2-1 ruling, the Court of Appeals for the Fourth Circuit has ruled that Maryland’s 2017 price-gouging law (HB 631) is unconstitutional. The law (Md. Code Ann., Health–General §§ 2-801 et seq.) had prohibited price gouging (defined as an… Continue Reading
Add some hearings.. 1983 Oversight on implementation of the Orphan Drug Act (Public Law 97-414) : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congress, first session, on reviewing the radioepidemiological tables and thyroid cancer… Continue Reading